Implementation of an enhanced recovery after surgery program in the treatment of uterine fibroids with focused ultrasound ablation surgery
作者全名:"Sang, Guowei; Zhang, Xin; Fan, Huamin; Ao, Xing; Chen, Yushan; Shi, Qiuling"
作者地址:"[Sang, Guowei; Zhang, Xin] Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China; [Fan, Huamin; Ao, Xing; Chen, Yushan] HAIFU Hosp, Chongqing, Peoples R China; [Shi, Qiuling] Chongqing Med Univ, Sch Publ Hlth & Management, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China"
通信作者:"Shi, QL (通讯作者),Chongqing Med Univ, Sch Publ Hlth & Management, State Key Lab Ultrasound Med & Engn, Chongqing, Peoples R China."
来源:INTERNATIONAL JOURNAL OF HYPERTHERMIA
ESI学科分类:CLINICAL MEDICINE
WOS号:WOS:000763105400001
JCR分区:Q2
影响因子:3.1
年份:2022
卷号:39
期号:1
开始页:414
结束页:420
文献类型:Article
关键词:ERAS; FUAS; uterine fibroids; perioperative care
摘要:"Background Enhanced recovery after surgery (ERAS) can reduce the length of hospital stay, incidence of surgery-related complications, and postoperative pain. We aimed to demonstrate the implementation of an ERAS pathway in the treatment of uterine fibroids with focused ultrasound ablation surgery (FUAS). Materials and Methods A retrospective data analysis was performed on clinical outcomes encompassing the following three phases: before ERAS (pre-ERAS), during adjustment of ERAS (interim-ERAS), and after the introduction of an ERAS program (post-ERAS). The purpose of describing the interim-ERAS was to provide references for the formulation of the program during the course of FUAS by describing the adjustment processes. Data from patients admitted to the hospital from September 2019 to December 2019 and April 2020 to November 2020 and who met the criteria for FUAS in the treatment of their uterine fibroids were examined. Length of stay, cost of surgery, postoperative pain score, utilization of postoperative analgesics, and incidence of postoperative adverse events were compared across the abovementioned three phases. Results Compared with the pre-phase, the cost of treatment and length of stay were reduced after the implementation of ERAS. The use of analgesics before leaving the operating room, as well as the incidence of postoperative nausea and vomiting, were also reduced. Conclusion The implementation of an ERAS protocol might benefit patients with uterine fibroids treated with FUAS in terms of requiring a shorter hospitalization period, lower costs, and reduced opioid use."
基金机构:National Natural Science Foundation of China [81872506]
基金资助正文:This study was supported by the National Natural Science Foundation of China [Grant No. 81872506].